肝癌肝动脉化疗栓塞后急性上消化道出血的相关因素  

Factors Related to Acute Upper Gastr ointestinal Bleeding after Transcatheter Arterial Chemoembol ization in Patients with Hepatocellular Carcinoma

作　　者：吴建新[1] 黄介飞[2] 于志坚[2] 孟宪镛[2] 李定国[1] 陆汉明[1] 

机构地区：[1]上海第二医科大学附属新华医院消化内科,上海200092 [2]南通医学院附属医院消化内科,江苏南通226001

出　　处：《癌症》2002年第8期881-884,共4页Chinese Journal of Cancer

摘　　要：背景与目的:原发性肝癌患者在施行肝动脉栓塞化疗后常并发急性上消化道出血。作者研究出血的相关因素,以帮助临床有效防治这一并发症。方法:208例中晚期原发性肝癌患者经影像学和AFP或病理检查确诊;采用Seldinger方法将动脉导管插入腹腔动脉、肝总动脉、肝固有动脉、肝左或右动脉,注入表阿霉素、顺铂、丝裂霉素、5-氟尿嘧啶(5-FU)以及碘化油或/和明胶海绵等;以呕血和/或黑便为依据诊断为上消化道出血,结合内镜检查和肝功能生化指标、血管选择情况、用药量等分析出血的相关因素。结果:208例中31例(14.9%)出现上消化道出血。内镜检查急性出血糜烂性胃炎18例、急性溃疡和Mallory-Weiss综合征各3例、食管静脉曲张破裂2例。肝功能Child-Pugh分级积分(B级)与并发出血呈正相关(r=0.59,P<0.005);导管插至腹腔动脉者或肝总动脉注射药物并发出血者(7/18,38.9%;18/38,47.4%),显著多于插至肝固有动脉或肝左、肝右动脉者(5/146,3.4%;P<0.005);化疗药物用量较大以及合用栓塞剂者出血发生率较高。结论:原发性肝癌患者动脉化疗栓塞后并发上消化道出血与患者肝功能分级、导管插入血管位置、化疗药物和栓塞剂用量大小等因素有关;认识这些因素,改进操作以及加强术后观察处理有助于减少上消化道出血的发生。Background &Objective:Acute upper gastrointestinal bleed ing(UGIB)often occurs after transcatheter arterial chemoembolization(TACE)in the patients with hepatocellular carcinoma (HCC).The authors studied the factors associated with UGIB for better prev ention and management of the complic ation.Methods:Epirubicin,cisplatin,mitomycin,5-fluorouracil,lipiodol and /or ge lfoam were infused via catheters inserted in ciliac artery,common hepatic artery,arteria hepatica propria,or left or right hepatic artery by Seidinger method in 208cases of advanced HCC confirmed by image techniques,α-fetoprotein(AFP)and /or pathology.Factors related to UGIB(vomiting of blood and /or melena,or p ositive fecal occult blood)were analyzed with reference to endoscopy, biochemical parameters of liver function,selection of blood vessels,a nd the amount of drugs.Results:Of 208patients,31cases were complicated with UGIB.Ac ute gastric mucosal lesion was confirmed in 18cases;acute ulcer in 3case s;Mallory-Weiss syndrome in 3cases;a nd esophageal varices bleeding in 2c ases.Positive correlation was foun d between B grade of Child-Pugh hepatic functio nal reserve and bleeding(r=0.59,P<0.005).The incidence of UGIB in patients in whom drugs were infused via ciliac artery(7/18,38.9%);or common hepatic artery(18/38,47.4%)was significantly higher than in those via arteria hepatica propria,left,or right hepatic artery(5/146,3.4%;P<0.005).Patients with larger amount of chemotherapy drug a nd embolization agent had higher ble eding rate.Conclusion:Many factors may be associated with UGIB after TACE in patients with HCC,such as higher score s of hepatic functional reserve in Child-Pugh grading,selection of blood vessels,and amount of drugs.In order to reduce the incidence of UGIB,these facto rs should be necessarily considered in improvem ent of TACE procedure,in inspection and management after TACE.

关 键 词：原发性肝癌 治疗 并发症 肝动脉化疗栓塞 

分 类 号：R735.7[医药卫生—肿瘤]